473 related articles for article (PubMed ID: 1334770)
1. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists.
Miaskowski C; Sutters KA; Taiwo YO; Levine JD
Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544
[TBL] [Abstract][Full Text] [Related]
3. Antinociception produced by receptor selective opioids. Modulation of supraspinal antinociceptive effects by spinal opioids.
Miaskowski C; Taiwo YO; Levine JD
Brain Res; 1993 Apr; 608(1):87-94. PubMed ID: 8388314
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of spinal opioid analgesia by supraspinal administration of selective opioid antagonists.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 596(1-2):41-5. PubMed ID: 1361418
[TBL] [Abstract][Full Text] [Related]
5. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
Miaskowski C; Taiwo YO; Levine JD
Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of antinociceptive and motor effects of supraspinal opioid agonists in the rat.
Franck LS; Miaskowski C; Putris J; Levine JD
Brain Res; 1991 Nov; 563(1-2):123-6. PubMed ID: 1664771
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat.
Miaskowski C; Sutters KA; Taiwo YO; Levine JD
Brain Res; 1991 Jul; 553(1):105-9. PubMed ID: 1933267
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
Bot G; Chahl LA; Brent PJ; Johnston PA
Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
[TBL] [Abstract][Full Text] [Related]
10. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
DeLander GE; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
[TBL] [Abstract][Full Text] [Related]
11. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
[TBL] [Abstract][Full Text] [Related]
12. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
Murray CW; Cowan A
J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats.
Przewłocka B; Dziedzicka M; Lasoń W; Przewłocki R
Life Sci; 1992; 50(1):45-54. PubMed ID: 1345879
[TBL] [Abstract][Full Text] [Related]
14. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids.
Sutters KA; Miaskowski C; Taiwo YO; Levine JD
Brain Res; 1990 Oct; 530(2):290-4. PubMed ID: 1979930
[TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
16. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
Danzebrink RM; Green SA; Gebhart GF
Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489
[TBL] [Abstract][Full Text] [Related]
17. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
18. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
19. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
